Advances in Small Animal Medicine & Surgery
Volume 20, Issue 11 , Pages 1-3 , November 2007

Emerging treatments for granulomatous meningoencephalomyelitis (GME)

  • Joan R. Coates, DVM, MS, Diplomate ACVIM (Neurology) (Associate Professor)

References 

  1. Higginbotham MJ , Kent M , Glass EN . Noninfectious inflammatory central nervous system diseases in dogs . Compend Cont Ed: Pract Vet . 2007;29(8):488–501
  2. Munana KR , Luttgen PJ . Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982-1996) . J Am Vet Med Assoc . 1998;212:1902–1906
  3. Coates JR , Barone G , Dewey CW , et al.   Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004) . J Vet Int Med . 2007;21:100–106
  4. Zarfoss M , Schatzberg S , Venator K , et al.   Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown etiology in 10 dogs . J Sm Anim Pract . 2006;47:588–595
  5. Adamo FP , O'Brien RT . Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs . J Am Vet Med Assoc . 2004;225:1211–1216
  6. Sturges BK , LeCouteur RA , Gregory CR , et al.   Leflunomide for treatment of inflammatory or malacic lesions in three dogs: A preliminary clinical study . J Vet Int Med . 1998;12:207

PII: S1041-7826(07)00166-1

doi: 10.1016/j.asams.2007.10.001

Advances in Small Animal Medicine & Surgery
Volume 20, Issue 11 , Pages 1-3 , November 2007